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for isolated CABG 10etwean Jury 1 1993 and 13o¢ 31 1995, Patients wem 
censored from follow-up at the Itme of CABG, 
Results: 101 paIients had >~ 50% LM stenoats (by QCA) and 103 had 
LMEQ dis~ase, Med=nn age w~~t~ 66 (57-69, IO mngo) an~ 64 (57-69) yeam, 
2S and 34 wero warnen, 43 and 40 had Claaa IV angina, and nl~lifln wait5 for 
CABG wem 64 (12-215) ~nd 95 (21-365) d~y~ in Iho LM and LMEQ groups, 
Fraedom Irom cleatll at I y~r  was 0,79 in fl!l LM and 0+94 in LM patmflls 
will1 C la~ I-tll angina ~t mfell'~l, and 0,98 and 0,96 l~ eoch LMEQ Group, 
"rhefo warn fmquem re~ldmmsmn~, ~t,m!ly wtth un~table angina; fme0om 
ffom death, MI of f~~asmn w~~ 0,46 and 0,53 in t l~ LM and LMEQ 
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Co~"~seOns: ~~wal  in pa~e~s ~ LM oe LMEQ ~sease may t~e 
helfer m the l~ 's  lhan in the tgT0*s ~ madft~ss~~rt is frequent+ resoume 
u~tmal~n is ~.  and po~ent~~y peevemable deaths oocur 
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Pat Je~t , ,Phy~~ ~ ~ t  on 
CaRflovas~W Risk Faclm" Management 
S. Mofa. R.S. Sta~fon:l, R.E. C ~  T I~ ,  R.C. Pastemak. 
A~, ~ « - ~  C .~ Hos~~L Bosron. MA. USA 
Effe¢5"ve t;~sk f~ct~r (RF) management ¢Sz~~-,-,ls on rer~d~e commtm~catmn 
p t ~  an0 pate, ms (pLs)+ We ùweslJgated levsls ol co~cor- 
dance ~ pts, ~ and g~e medcal recoed to: selected RF 
acth,,d~s. 
Me~ho0rs: A cross-sec~onal sunmy of 234 pts in a can:hology pract~ce 
composed of 28 cardmkx~~'ts was undem=ken. ~ i ~  with l~S 
wem conducted 3.-7 cZays after the vts=t Infom~tmn from PtS and ~ 
was compamd v~h 0~cumentatmn m the medmal reCord for bkxxl P~~sure 
(BP) values, chotesterol estmg, drei assessment and ~ cou~seling. 
Resu/~: BP measuremen~ wem rel~led by 99% of phys;oans, 97% of 
pts, and 94% of me(bcal records. Chdlesterol teslmg was ~-~~ofted by 19'% of 
phys~ctans. 13% of pts. and 15% of me~cal rocords. D~el assessments w~~re 
repoded by 74% ol phys~c~ans, 51% ol pts, and 43% of med~cal r rds. 
Dlet oDunsellft 0 was repolled by 5~~o Of 13~JSfCta, Rs, 3~ó et pl.% and 24% 
of medica! records. Pts + recaP of systolic and diastohc BP measurements 
conelated str0ngly ~ actual values (coaela~on coeffpc~ms 0.96 and 0.91. 
p < 0.001; mean systdl¢ BP d~fference 1.6, SD 4.6. 
Conctusion: Pt.phys~an-medcal mcord agreement on RF mtewent~D~s 
dudng visits was strO~J for BP and cholesterol. Cornl~red ~~ patient and 
medcal recoKI documentat~on, physioans over.mported d~et inlerventmns, 
suggesting Ihat (~Jferent baseline RFs influe+¢'e commt~n~cat*on a d docu- 
mematmn of RF lnte~em:ons. 
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~ Lack of Associatlon of Intermediate CPK-MB 
Elevation and Late Mortality in Patients l~eated With 
intracoronary Staats 
J.F. Saucedo, J.J. Popma, R. Mehran, T. Bucher, A.S. Abizaid, M Curran. 
M. Mastoor, K .M Kent, A. Pichard, L Satter, MB.  Leon. Washmgton 
Hospital Center, Washington. D.C., USA 
We have previously reported an associalion between intermediate level 
CK-MB etevalion and late mortality after atheroablalive new device ang~o- 
plasty. To detemline whether this assOciation is also present in pts undergoi~g 
steht pl~cement, we reviewed the laie cfinical outcome of 900 consecutive 
pts (1213 lesions) undergoing successful steming in nalive vessels. Postpro- 
cedu~~ CK-MB wem normal IN) in 65%, 1-5 × N in 26% and >5 x N in 8% 
ol pta. Although late mortaldy was h~gher ,n thoSe pt$ w~th CK-MB ~5 , N, 
no asso¢iatlon was found botw6~n intormediate level CK-MB etevaI~on and 
laie mortatity, (Table). 
Norm~lN = 5~5 +I-~ • Nn=~38 +5 . Nn = T'/ 
Oe~l~, % 1 ? 1 2 09" 
MI, % 10 U~ 4.1" 
CAOG, % 6 '2 9.8 # 3 
PTCA, % te, 0 t4 t ;~3« 
"p " 005, "p ' 00t compam~0 w'~ normal CK.MI~ (]m~~p 
MLd1~vanate analypis ,~lso ahow~l and ifctease nsk for MACE m me 
h~9hesl CK+MB group IRR: 1,?'0. p .~ 0.05) hut not in the in te~ 
CK+MB 0r0up (p ; 02.), 
We ~u~e:  1) In te~iate  CK,MB el~/a1ù~p are Imquont alte+ coro- 
naqt slenling (26%), and 2) am not assocm~ w~ 18te mo~la!~ of Clin~al 
events. 
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SK S~am',a, A Kini, S+ Kai, R. Vtdhm'L G, Oangas, S. Duwun, TP  Cocke, 
J.D. Marmur, JA  Ambmse. Moun~ Sm~ Hod~bat, N~, US4 
Creatine Kmase-MB (CK-MB) eteval~:m hes ~ shown to occur after suc, 
ceasful mterve,~~m and is a ~redictor of laie cardiac events, MI a l~ death. 
PmFm~~a~/mports I~ave mvealed higher CK-MB elevation after newm, dle- 
vces (D} su~ as mtaS~r~ atl~re~,~my (RA), steht, dtmctional att~mctomy 
(DCA), lranslummal extraclmnal calheter ~C) ,  um-ùpared to dagoon 
plasty (PTCA). We ratx~ the incide~,e of CK-MB enzyme ekavat~ w~min 
24 hfs ol mlerven1~on m 842 consecutl~e patHenIs in relaIK~n Io (~flemnt 
lypes of mte~=~on. Pat~s~ ~ a~me MI (38), Urokmase mlusmn (8) 
~r elevated pre~m:edumt CK-MB (10), wem e~ck~led. Procedural ~uccass 
(<50% drum. obstmctmn post pm~ed~re) was ga.L~o, and maieù- compli- 
c~ons  of acute closure, subacute ~ lhmmbosis, Q-wave MI, e inerem 
CABG, or ~ i  dea~ occurmd in 6 paltents (0.7%). 
Rasur .  Overall ~c~-~e of any CK-MB elevation was t5,7%, and was 
not d~,~,~~; after sm~te rassel vemus multip~ vessei mtervent~n CK-M~ 
in variou~ de~loß~: 
CK-II,~ PTCA RA STeht DCA TEC ~ D 
n=10S n=23~ n=232 n=25 n=20 n=222 
.0uly ase 67% 143%" 168%" 2C~~=" L:~'%" 194'%" 
I»3X 4 B«o t0 ~'= 1Q 8"%, 210% ~P~= 153'%, 
3-5X O 1 3'== 3 4% 0 5% 36% 
-SX t ~~'ù 2 ~% 26% Q S% 05% 
• p - 0 005. vS PTCA Them was a trend toward Iowef CK-MB eteval~n alter ItA alo~ vs 
~~L.~ aloae (p - 0 07) (~'st~e me ~'nda~ ReoPm 'Ja":" ('~P';" RA, 29% In stahl P = NS) 
Con¢tusä~~: CK-MB e~evatmn is mom frequen! after new dav¢e inter- 
uont~ons corngared to PTCA. Contra W to pnor data, RA was not assocmtod 
w~h a hggher ~ of CK-MB elevatù~ comdared to the stem alone+ Thrs 
may be duO to t m ~ t s  in RA techr~que and a sllghIty higher i ~  
of s~de branch occfus~on in the steht group. 
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Does the Magnitude of Cm~ne K in ,R  E .levatio.n 
Impact SurvivM in Non-O My~,¢ardlal Intarclmn Æn~r 
Coronary Interventions? 
Z. Ghazzal. P Chalasant, Y. Shen, N. Chronos. S.B+ King, IIL 
WS. Weinl~aub. Emory Unnrers~ty Aflanfa. GA. USA 
Elevatmns of cmatJnine klasse (CK) after angioplasty has been shown to 
have an adv~rse outcome. In Ihis StUdy we focused on the relaIlon of the 
magn=tude c t CK elevation to surwraL Patients whO underwent angmplasty 
wem dMded into tour groups: Group I (CK <250 mg/dl: n = 14034); Group Il 
(,CK 250-500 mg/dl; n = 6740), Group Ill (CK 500-750 mg/dl; n = 185); Group 
IV (CK >750 mg/dl). Patients wdh Q wave M[s compficating angiuplasty 
wem excluded. Sunnval was not decreased until CK was above 500 mg/dl 
(left figure). The increased rnortality mlated to CK elevation was limited to 
patients having rein grafl procedums (right figum). CK elevation >750 mg/dl 
was noted in 3.7% of ve;n graft procedums vs 2.6% of cf native vessel 
procedures ~p = 0.02). CK elevation w~s auch more common in patients 
with proceduml complications (acute closure, side branch closuro or distal 
embOlization (19%) vs an uncomplicated procedum (0.27%, p < 0.0001). 
Conclusions: 1. EL,~ralion of CK post PTCA atxwe 500 mg/dl has a neg- 
ative impact on sun~ival, but only in patients with vein graft procedures. 
